International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: https://doi.org/10.5281/zenodo.14556991
Original Research Article
Determining correlation of serum uric acid and Lipid levels in Female patients of Acute Ischemic stroke
Published
Dec. 26, 2024
Abstract

Background: Stroke is a growing disease and it is the second common cause of death in the world after coronary heart disease. In patients with acute stroke hyperuricemia was significantly higher than normal population with associated dyslipidemia..Female sex is still an independent predictor ofpoor prognosis even when adjusting for other predictors of functional outcome. Aim: Serum uric acid levels and serum lipid levels in female patients with ischemic cerebrovascular accident. Material and Methods: This was a cross-sectional study carried out between July 2019 – September 2019, which included 44 female cases of acute ischemic stroke. Serum uric acid levels and serum lipid levels was done in all the patients and was statistically analyzed. Result:Among the 44 female patients, 33 (75%) were postmenopausal and 11(25%) werepremenopausal. The mean age in study was 58.09±15.23. Hyperurecimic patients were higher inpostmenopausal women as compared to premenopausal The study showed that patients were withboth dyslipidemia and hyperuricemia.The positive correlation was present between serum uric acid level and Total Cholesterol, Triglyceride, LDL level. The negative correlation was present between serum uric acid level and HDL level. The patients with decreased HDL with Hyperuricemia were 15.90% (7 out of 44). Conclusion: Hyperuricemia and its accompanying dyslipidemia can be considered as the risk factor for acute ischemic stroke.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
1530 Views
202 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved